LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Ito, Y.; Nakamura, T.; Saito, K.; Moriwaki, H.; Muto, Y.; Watanabe, K.; Ueno, K. (2011)
Publisher: Microbial Ecology in Health and Disease
Journal: Microbial Ecology in Health and Disease
Languages: English
Types: Article
Subjects:
In an attempt to elucidate the pathophysiological significance of intestinal flora in hepatic encephalopathy, the faecal flora as well as production of toxic substances and drug susceptibility of the isolates from faeces were serially examined in six patients with chronic recurrent hepatic encephalopathy. Significant changes in the faecal flora accompanied with those in toxic substances (ammonia, short-chain fatty acids) and clinical features were observed in three cases who had been administered antimicrobial agents. Administration of antimicrobial agents in the three cases was revealed to be one of the important precipitating factors of hepatic encephaiopathy, due mainly to the induction of overgrowth of toxic substance-producing organisms, such as Clostridiums pecies, which produced ammonia and short-chain fatty acids. Moreover, administration of polymyxin B brought about the overgrowth of Morganella morganii, which produced large amounts of ammonia and methanethiol. Clinical use of conventional antimicrobial agents should be carefully decided in patients with hepatic encephalopathy.Keywords: Hepatic encephalopathy; Faecal flora; Ammonia; Short-chain fatty acids; Antimicrobial agent; Clostridium species.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • I . Adachi Y, Enomoto M, Adachi M, Suwa M, Nagamine Y, Nanno T, Hashimoto T, Inoue H, Yamamoto T. (1982). Enteric coated polymyxin B in the treatment of hyperammonemia and endotoxemia in liver cirrhosis. Gastroenterologiu Juponica 17,550-557.
    • 2. Al Mardini H, Leonard J, Bartlett K, Lloyd S, Record CO. (1988). Effect of methionine loading and endogenous hypermethioninaemia on blood mercaptans in man. Clinica Chimica Acta 176, 83-90.
    • 3. Association of Inuyama Symposium Publication. (1982). The Criteria of Fluminant Hepatitis in Literature of the 12th lnuyarna Symposium. Tokyo, Chugai Medical Publications, p. 124(in Japanese).
    • 4. Berk DP, Chalmers T. (1970). Deafness complicating antibiotic therapy of hepatic encephalopathy. Annals oflnternal Medicine 73,393-396.
    • 5. Bolton RP. (1979). Clostridium dificile-associated colitis after neomycin treated with metronidazole. British Medical Journal 2, 1479-1480.
    • 6. Brown CL, Hill MJ, Richards P. (1971). Bacterial ureases in uraemic men. Lancet ii, 406408.
    • 7. Committee for Revision of MIC Determination Method. (1981). Revision of minimal inhibitory concentration (MIC) determination method. Chemotherapy ( T o k y o )2 9 , 7 6 7 9 (in Japanese).
    • 8. Conn HO, Lieberthal MM. (1979). Mechanism of Action of Lactulose. The Hepatic Coma Syndromes and Lactulose. Baltimore, Williams and Wilkins, pp. 278-294.
    • 9. Cummings JH, Pomare EW, Branch WJ, Naylor CPE, Macfarlane GT. (1987). Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28, 1221-1227.
    • 10. Dawson AM. (1978). Regulation of blood ammonia. Gut 19,504509.
    • 11. Fisher CJ, Faloon WW. (1957). Blood ammonia levels in hepatic cirrhosis. Their control by the oral administration of neomycin. New England Journal of Medicine 256, 103@1035.
    • 12. George WL, Rolfe RD, Finegold SM. (1980).Treatment and prevention of antimicrobial agent-induced colitis diarrhea. Gastroenterology 79,366372.
    • 13. Hill MJ, Drasar BS. (1975). The normal colonic bacterial flora. Gut 16,318-323.
    • 14. Hirayama C, Ichida F, Takahashi Y, Koizumi T, Sat0 S, Kosaka Y, Wakui K, Shimada Y, Yoshiba A, Hattori N, Ooya T, Takino T, Takeda H. (1982). A controlled clinical trial of nicotinohydroxamic acid and neomycin in advanced chronic liver disease. Digestion 25, 115-123.
    • 15. Hoyumpa AM, Schenker S. (1 982). Perspectives in hepatic encephalopathy. Journal of Laboratory and Clinical Medicine 100,477487.
    • 16. Jacobsen ED, Prior JT, Faloon WW. (1960). Malabsorptive syndrome induced by neomycin: morphologic alterations in the jejunal mucosa. Journal of Laboratory and Clinical Medicine 56,245-250.
    • 17. Krieg NR, Holt JG. (1984). Bergey's Manual of Systematic Bacteriology, Vol 1. Baltimore, Williams and Wilkins.
    • 18. Maruta K, Yoshihara I. (1983). Effectsofthe Italian ryegrass meal and the mixed preparation of L. acidophilus and S .,faecalis added to commercial formula feed. Bulletin of the Faculty of Agriculture Niigata University 35,45-53 (in Japanese).
    • 19. McClain CJ, Zieve L, Doizaki WM, Gilberstadt S, Onstad GR. (1980). Blood methanethiol in alcoholic liver disease with and without hepatic encephalopathy. Gut21,318-323.
    • 20. Mitsuoka T. (1982). Special quantitative study of intestinal flora. In: Ueno K (ed.) Procedures for Isolation and Identijication of Anaerobic Bacteria. Tokyo, Saikon shuppan, pp. 63-104 (in Japanese).
    • 21. Mondzac A, Ehrlich GE, SeegmillerJE. (1965). An enzymatic determination of ammonia in biological fluids. Journal of Laboratory and Clinical Medicine 66,52653 1.
    • 22. Moore WEC, Cat0 EP, Holdeman LV. (1978). Some current concepts in intestinal bacteriology. American Journal of Clinical Nutrition 31, S33-S42.
    • 23. Morgan MH, Read AE, Speller DCE. (1982). Treatment of hepatic encephalopathy with metronidazole. Gut 23, 1-7.
    • 24. Muto Y. (1966).Clinical study on the relationship of short-chain fatty acids and hepatic encephalopathy. Japanese Journal of Gastroenterology 63, 19-32 (in Japanese).
    • 25. Onstad GR, Zieve L. (1979).What determines blood ammonia? Gastroenterology 77,803-805.
    • 26. Park NJ, Fenton JCB. (1973). A simple method for the estimation of plasma ammonia using an ion specific electrode. Journal of Clinical Pathology 26, 802-804.
    • 27. Phear EA, Ruebner B, Sherlock S, Summerskill WHJ. (1956). Methionine toxicity in liver disease and its prevention by chlortetracycline. Clinical Science 15,93-117.
    • 28. Pitcher DG, Malnick H. (1984). Identification of Brevibacterium from clinical sources. Journal of Clinical Pathology 37, 1395-1 398.
    • 29. Ruppin H, Bar-Meir S, Soergel KH, Wood CM, Schmitt MG. (1980).Absorption of short chain fatty acids by the colon. Gastroenterology 78,1500-1507.
    • 30. Sakazaki R. (1967). Media for physiological and biochemical characterization. Baitigaku kakuron ( I ) , Saikinbaitigakukouza 111. Kindaiigakushya, Tokyo 73-222 (in Japanese).
    • 31. Sneath PHA, Mair NS, Sharpe ME, Holt JG. (1 986). Bergey 's Manual of Systematic Bacteriology, Vol2. Baltimore, Williams and Wilkins.
    • 32. Sutter VL, Citron DM, Edelstein MAC, Finegold SM. (1985). Special quantitative flora studies. In: Wadsworth Anaerobic Bacteriology Manuul. culture media. In: Ueno K (ed.) Procedures.for Zso4th edn. Belmont, Star Publishing Company. lution and Identification of Anaerobic Bacteria. pp. 92-1 27. Tokyo, Saikon shuppan, pp. 45-62 (in Japanese).
    • 33. Tarao K, Ikeda T, Hayashi K, Sakurai A. (1985). 37. Vince AJ, Burridge SM. (1980). Ammonia producClinical significance of anaerobic gram negative tion by intestinal bacteria: the effects of lactose, lacbacteria in hepatic encephalopathy and therapeutic tulose and glucose. Journal of Medical Microbiology effects of vancomycin hydrochloride o n hepatic 13,177-191. encephalopathy. Japanese Journul of Gastroentero- 38. Zieve FJ. Zieve L, Doizaki WM, Gilsdorf RB. log~82,1875-1883. ( I 974).Synergism between ammonia and fatty acids
    • 34. Tisdale WA, Fenster LF, Klatskin G. (1960).Acute in the production of coma: implications for hepatic staphylococcal enterocolitis complicating oral neo- coma. Journul of' Pharmacology und Experimentul mycin therapy in cirrhosis. New Englund Journul of Therupeutics 191, 10-16. Medicine 263, 10141016. 39. Zieve L, Doizaki WM, Zieve FJ. ( 1 974). Synergism
    • 35. Ueno K , Kobayashi T, Watanabe K. (1984). Anti- between mercaptans and ammonia or fatty acids microbial agent-associated colitis: consideration in in the production of coma: a possible role for bacteriological field. Journul of' Adult Diseases 14, mercaptans in the pathogenesis of hepatic coma. 1039-1049 (in Japanese). Journal of Laboratory and Clinical Medicine 83,
    • 36. Ueno K, Watanabe K , Isono M. (1982). Gas liquid 1 6 2 8 . chromatographic analysis of metabolites in spent
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article

Collected from